Capricor Therapeutics Price to Free Cash Flow Ratio 2010-2024 | CAPR
Historical price to free cash flow ratio values for Capricor Therapeutics (CAPR) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Capricor Therapeutics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-11-20 | 18.92 | 0.00 | |
| 2024-09-30 | 15.21 | $-1.22 | 0.00 |
| 2024-06-30 | 4.77 | $-1.25 | 0.00 |
| 2024-03-31 | 6.79 | $-1.24 | 0.00 |
| 2023-12-31 | 4.89 | $-1.03 | 0.00 |
| 2023-09-30 | 3.42 | $-0.93 | 0.00 |
| 2023-06-30 | 4.78 | $-0.85 | 0.00 |
| 2023-03-31 | 4.22 | $-0.75 | 0.00 |
| 2022-12-31 | 3.86 | $0.06 | 60.88 |
| 2022-09-30 | 6.00 | $0.14 | 43.96 |
| 2022-06-30 | 3.49 | $0.26 | 13.63 |
| 2022-03-31 | 3.43 | $0.34 | 10.21 |
| 2021-12-31 | 2.93 | $-0.78 | 0.00 |
| 2021-09-30 | 4.02 | $-0.87 | 0.00 |
| 2021-06-30 | 5.13 | $-0.82 | 0.00 |
| 2021-03-31 | 4.68 | $-0.66 | 0.00 |
| 2020-12-31 | 3.43 | $-0.68 | 0.00 |
| 2020-09-30 | 5.25 | $-0.82 | 0.00 |
| 2020-06-30 | 4.60 | $-1.08 | 0.00 |
| 2020-03-31 | 1.20 | $-1.54 | 0.00 |
| 2019-12-31 | 1.28 | $-1.84 | 0.00 |
| 2019-09-30 | 3.70 | $5.06 | 0.73 |
| 2019-06-30 | 3.32 | $4.53 | 0.73 |
| 2019-03-31 | 4.66 | $3.86 | 1.21 |
| 2018-12-31 | 4.10 | $3.00 | 1.37 |
| 2018-09-30 | 10.50 | $-3.77 | 0.00 |
| 2018-06-30 | 13.40 | $-4.05 | 0.00 |
| 2018-03-31 | 13.60 | $-4.48 | 0.00 |
| 2017-12-31 | 15.80 | $-5.32 | 0.00 |
| 2017-09-30 | 30.30 | $-6.81 | 0.00 |
| 2017-06-30 | 8.30 | $-6.59 | 0.00 |
| 2017-03-31 | 33.80 | $-7.53 | 0.00 |
| 2016-12-31 | 26.60 | $-7.90 | 0.00 |
| 2016-09-30 | 32.43 | $-8.44 | 0.00 |
| 2016-06-30 | 39.50 | $-9.53 | 0.00 |
| 2016-03-31 | 25.40 | $-8.05 | 0.00 |
| 2015-12-31 | 30.74 | $-6.90 | 0.00 |
| 2015-09-30 | 40.50 | $-6.36 | 0.00 |
| 2015-06-30 | 50.50 | $-6.24 | 0.00 |
| 2015-03-31 | 86.20 | $-10.37 | 0.00 |
| 2014-12-31 | 37.50 | $0.66 | 56.81 |
| 2014-09-30 | 38.50 | $2.76 | 13.93 |
| 2014-06-30 | 44.00 | $0.32 | 138.23 |
| 2014-03-31 | 85.00 | $4.86 | 17.49 |
| 2013-12-31 | 32.50 | $-5.90 | 0.00 |
| 2013-09-30 | 25.00 | $14.40 | 1.74 |
| 2013-06-30 | 25.00 | $13.08 | 1.91 |
| 2013-03-31 | 50.00 | $4.37 | 11.44 |
| 2012-12-31 | 25.00 | $-2.09 | 0.00 |
| 2012-09-30 | 55.00 | $-46.14 | 0.00 |
| 2012-06-30 | 50.00 | $-44.63 | 0.00 |
| 2012-03-31 | 250.00 | $-51.70 | 0.00 |
| 2011-12-31 | 275.00 | $-62.27 | 0.00 |
| 2011-09-30 | 315.00 | $-58.75 | 0.00 |
| 2011-06-30 | 390.00 | $-68.78 | 0.00 |
| 2011-03-31 | 410.00 | $-63.88 | 0.00 |
| 2010-12-31 | 310.00 | $-67.15 | 0.00 |
| 2010-09-30 | 315.00 | $-72.78 | 0.00 |
| 2010-06-30 | 165.00 | $-69.77 | 0.00 |
| 2010-03-31 | 490.00 | $-96.12 | 0.00 |
| 2009-12-31 | 605.00 | $-113.81 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.839B | $0.025B |
| Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Stryker (SYK) | United States | $148.171B | 33.39 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Medtronic (MDT) | Ireland | $109.010B | 16.19 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| Haemonetics (HAE) | United States | $4.260B | 20.79 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Neogen (NEOG) | United States | $3.270B | 37.72 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |